{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T22:04:10Z","timestamp":1795212250434,"version":"4.10.3"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>We aimed to compare the diagnostic performance of <jats:sup>68<\/jats:sup>Ga-FAPI-04 (FAPI) in comparison to <jats:sup>68<\/jats:sup>Ga-DOTATATE (SSTR) PET\/CT for patients presenting with recurrent medullary thyroid carcinoma (MTC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods<\/jats:title>\n            <jats:p>Sixteen MTC patients with elevated calcitonin levels (&gt;150 pg\/mL) underwent FAPI and SSTR PET\/CT. Two nuclear medicine physicians evaluated all images, categorizing lesions into locoregional metastases, mediastinal lymph nodes (LNs), liver, and bone metastases. SUV<jats:sub>max<\/jats:sub> and tumor-to-background ratio were recorded. PET modalities were compared using the McNemar test. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of FAPI and SSTR PET were calculated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The cohort comprised 16 patients (50% female; mean age 50 \u00b1 17 years). Median calcitonin and CEA levels were 6234 pg\/mL and 17.3 ng\/mL, respectively. In patient-based analysis, SSTR exhibited higher diagnostic sensitivity compared with FAPI (88% vs 81%), resulting a statistically significant difference (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.004). Mean SUV<jats:sub>max<\/jats:sub> and tumor-to-background ratio values were 10.3 and 5.35 for FAPI, and 9.7 and 11.9 for SSTR PET, respectively. In lesion-based analyses, FAPI demonstrated higher accuracy than SSTR for cervical LNs (91.9% vs 50%), mediastinal LNs (94.9% vs 54.4%), and liver metastases (57.4% vs 7.3%), respectively. Notably, 31% of patients (n = 5) with FAP-expressing liver lesions showed no uptake on SSTR imaging. MRI confirmed liver metastases in 3 of these patients; however, 2 FAP-expressing lesions were confirmed as hemangiomas. False-positive findings of DOTA primarily included reactive LNs and bone hemangiomas.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>FAPI PET presents promising outcomes in detecting metastases in recurrent MTC patients. Although its diagnostic performance matches SSTR on a per-patient basis, FAPI PET exhibits superior sensitivity and accuracy in lesion-based analyses, notably for liver and bone metastases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000005558","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T17:00:16Z","timestamp":1732294816000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Head-to-Head Comparison of 68Ga-FAPI-04 and 68Ga-DOTA-TATE PET\/CT in Recurrent Medullary Thyroid Cancer"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3786-8052","authenticated-orcid":false,"given":"Emine Goknur","family":"Isik","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6945-2003","authenticated-orcid":false,"given":"Duygu","family":"Has Simsek","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-944X","authenticated-orcid":false,"given":"Nurdan","family":"Gul","sequence":"additional","affiliation":[{"name":"Department of Endocrinology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4086-675X","authenticated-orcid":false,"given":"Sukru Mehmet","family":"Erturk","sequence":"additional","affiliation":[{"name":"Department of Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9766-1491","authenticated-orcid":false,"given":"Fikret","family":"Buyukkaya","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0732-4764","authenticated-orcid":false,"given":"Ozlem","family":"Soyluk Selcukbiricik","sequence":"additional","affiliation":[{"name":"Department of Endocrinology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Yalin","family":"Iscan","sequence":"additional","affiliation":[{"name":"Division of Endocrine Surgery, Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep G\u00f6zde","family":"\u00d6zkan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1267-2379","authenticated-orcid":false,"given":"Yasemin","family":"Sanli","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5533-0969","authenticated-orcid":false,"given":"Ayse","family":"Mudun","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1158-5361","authenticated-orcid":false,"given":"Serkan","family":"Kuyumcu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"bib1-20250107","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","year":"2015","journal-title":"Thyroid"},{"key":"bib2-20250107","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.clon.2010.05.002","article-title":"Medullary thyroid carcinoma","volume":"22","year":"2010","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"bib3-20250107","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1089\/thy.2018.0067","article-title":"Incidence and survival of thyroid cancer in children, adolescents, and young adults in Denmark: a nationwide study from 1980 to 2014","volume":"28","year":"2018","journal-title":"Thyroid"},{"key":"bib4-20250107","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/RLU.0000000000002940","article-title":"Comparison of 5 different PET radiopharmaceuticals for the detection of recurrent medullary thyroid carcinoma: a network meta-analysis","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib5-20250107","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archsurg.142.3.289","article-title":"Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis","volume":"142","year":"2007","journal-title":"Arch Surg"},{"key":"bib6-20250107","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1530\/EJE-14-0076","article-title":"Small medullary thyroid carcinoma: post-operative calcitonin rather than tumour size predicts disease persistence and progression","volume":"171","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"bib7-20250107","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00259-019-04458-6","article-title":"EANM practice guideline for PET\/CT imaging in medullary thyroid carcinoma","volume":"47","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib8-20250107","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12020-019-01895-z","article-title":"Novel PET tracers: added value for endocrine disorders","volume":"64","year":"2019","journal-title":"Endocrine"},{"key":"bib9-20250107","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12020-012-9631-1","article-title":"Diagnostic performance of gallium-68 somatostatin receptor PET and PET\/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis","volume":"42","year":"2012","journal-title":"Endocrine"},{"key":"bib10-20250107","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/978-3-642-27994-2_21","article-title":"Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature","volume":"194","year":"2013","journal-title":"Recent Results Cancer Res"},{"key":"bib11-20250107","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s00259-017-3728-y","article-title":"Guideline for PET\/CT imaging of neuroendocrine neoplasms with (68)Ga-DOTA-conjugated somatostatin receptor targeting peptides and (18)F-DOPA","volume":"44","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib12-20250107","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.3390\/cancers14174172","article-title":"Thyroid cancer and fibroblasts","volume":"14","year":"2022","journal-title":"Cancers (Basel)"},{"key":"bib13-20250107","first-page":"59","article-title":"Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma","volume":"31","year":"2007","journal-title":"Int J Oncol"},{"key":"bib14-20250107","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib15-20250107","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"A tumor-imaging method targeting cancer-associated fibroblasts","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib16-20250107","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"(68)Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"bib17-20250107","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer","volume":"47","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib18-20250107","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1089\/thy.2023.0008","article-title":"Head-to-head comparison of [(68)Ga]Ga-DOTA.SA.FAPi and [(68)Ga]Ga-DOTANOC positron emission tomography\/computed tomography imaging for the follow-up surveillance of patients with medullary thyroid cancer","volume":"33","year":"2023","journal-title":"Thyroid"},{"key":"bib19-20250107","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s12020-021-02800-3","article-title":"Liver metastases from medullary thyroid carcinoma detected on (68)Ga-FAPI-04 PET\/CT","volume":"74","year":"2021","journal-title":"Endocrine"},{"key":"bib20-20250107","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1210\/jc.2018-00193","article-title":"Comparison of 68Ga PET\/CT to other imaging studies in medullary thyroid cancer: superiority in detecting bone metastases","volume":"103","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"bib21-20250107","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"(68)Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"bib22-20250107","first-page":"2417","article-title":"Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma","volume":"83","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"bib23-20250107","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s12020-018-1706-1","article-title":"SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival","volume":"62","year":"2018","journal-title":"Endocrine"},{"key":"bib24-20250107","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/apm.12584","article-title":"Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis","volume":"124","year":"2016","journal-title":"Apmis"},{"key":"bib25-20250107","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12149-013-0718-4","article-title":"Physiological and tumoral uptake of (68)Ga-DOTATATE: standardized uptake values and challenges in interpretation","volume":"27","year":"2013","journal-title":"Ann Nucl Med"},{"key":"bib26-20250107","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1053\/j.semnuclmed.2023.02.001","article-title":"FAPI-avid nonmalignant PET\/CT findings: an expedited systematic review","volume":"53","year":"2023","journal-title":"Semin Nucl Med"},{"key":"bib27-20250107","doi-asserted-by":"crossref","first-page":"989595","DOI":"10.3389\/fonc.2022.989595","article-title":"Non-tumoral uptake of (68)Ga-FAPI-04 PET: a retrospective study","volume":"12","year":"2022","journal-title":"Front Oncol"},{"key":"bib28-20250107","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/RLU.0000000000003998","article-title":"Differentiation of reactive lymph nodes and tumor metastatic lymph nodes with 68Ga-FAPI PET\/CT in a patient with squamous cell lung cancer","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib29-20250107","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/RLU.0000000000003939","article-title":"68Ga-FAPI PET\/CT distinguishes the reactive lymph nodes from tumor metastatic lymph nodes in a patient with nasopharyngeal carcinoma","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib30-20250107","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1210\/jc.2016-2815","article-title":"Bone metastases and skeletal-related events in medullary thyroid carcinoma","volume":"101","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"bib31-20250107","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00259-017-3701-9","article-title":"(68)Ga-DOTATATE PET\/CT in recurrent medullary thyroid carcinoma: a lesion-by-lesion comparison with (111)In-octreotide SPECT\/CT and conventional imaging","volume":"44","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib32-20250107","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/RLU.0000000000000282","article-title":"(68)Ga DOTATATE uptake in vertebral hemangioma","volume":"39","year":"2014","journal-title":"Clin Nucl Med"},{"key":"bib33-20250107","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12020-019-01846-8","article-title":"(68)Ga-DOTANOC and (18)F-FDG PET\/CT in metastatic medullary thyroid carcinoma: novel correlations with tumoral biomarkers","volume":"64","year":"2019","journal-title":"Endocrine"},{"key":"bib34-20250107","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00259-009-1204-z","article-title":"Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET\/CT in the detection of recurrent medullary thyroid carcinoma","volume":"37","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib35-20250107","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","article-title":"The role of fibroblast activation protein in health and malignancy","volume":"39","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"bib36-20250107","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00259-022-06022-1","article-title":"[18F]FAPI PET\/CT in the evaluation of focal liver lesions with [18F]FDG non-avidity","volume":"50","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib37-20250107","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1097\/RLU.0000000000004965","article-title":"Elevated 18F-AIF-FAPI-04 uptake in hepatic hemangioma","volume":"49","year":"2024","journal-title":"Clin Nucl Med"},{"key":"bib38-20250107","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MNM.0000000000000240","article-title":"Comparison of 68Ga-DOTATATE PET-CT, 18F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma","volume":"36","year":"2015","journal-title":"Nucl Med Commun"},{"key":"bib39-20250107","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.1097\/RLU.0000000000004164","article-title":"First-in-human experience with 177Lu-DOTAGA.(SA.FAPi)2 therapy in an uncommon case of aggressive medullary thyroid carcinoma clinically mimicking as anaplastic thyroid cancer","volume":"47","year":"2022","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:01:39Z","timestamp":1736294499000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":39,"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005558","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,19]]}}}